Coronavirus (COVID-19) Update: FDA prepares for resumption of domestic inspections with new risk assessment system
Coronavirus (COVID-19) Update: FDA prepares for resumption of domestic inspections with new risk assessment system The U.S. Food and Drug Administration has been thoughtfully and deliberately determining the safest and most appropriate time to resume prioritized domestic inspections of FDA-regulated facilities and other associated activities since we first announced postponement in March. The White House Guidelines […]